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Membrane topologyNeisseria meningitidis is a major cause of meningitis. Although protective vaccination is available against
some pathogenic serogroups, serogroup B meningococci have been a challenge for vaccinologists. A family of
outer membrane lipoproteins, LP2086 (or factor H binding proteins, fHbp), has been shown to elicit
bactericidal antibodies and is currently part of a cocktail vaccine candidate. The NMR structure of the variant
LP2086-B01 in micellar solution provided insights on the topology of this family of proteins on the biological
membrane. Based on ﬂow cytometry experiments on whole meningococcal cells, binding experiments with
monoclonal antibodies, and the NMR structure in micellar solution, we previously proposed that LP2086-B01
anchors the outer bacterial membrane through its lipidated N-terminal cysteine, while a ﬂexible 20 residue
linker positions the protein above the layer of lipo-oligosaccharides that surrounds the bacteria. This
topology was suggested to increase the antigen exposure to the immune system. In the present work, using
micellar solution as a membrane mimicking system, we characterized the backbone dynamics of the variant
LP2086-B01 in both its lipidated and unlipidated forms. In addition, binding experiments with a Fab
fragment derived from the monoclonal MN86-1042-2 were also performed. Our data suggests that due to the
length and ﬂexibility of the N-terminal linker, the antigen is not in contact with the micelle, thus making
both N- and C-domains highly available to the host immune system. This dynamic model, combined with the
binding data obtained with MN86-1042-2, supports our previously proposed arrangement that LP2086-B01
exposes one face to the extracellular space. Binding of MN86-1042-2 antibody shows that the N-domain is
the primary target of this monoclonal, providing further indication that this domain is immunologically
important for this family of proteins.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Meningitis caused by the bacterium Neisseria meningitidis results
in signiﬁcant mortality and morbidity in humans. Of the ﬁve bacterial
serogroups associated with the disease (A, B, C, Y and W135),
successful preventive vaccination has been achieved for serogroups A,
C, Y and W135, through the use of capsular polysaccharides
conjugated to proteins [1]. In spite of the fact that serogroup B isorin A; PorB, porin B; rLP2086,
lipidated P2086; rLP2086-B01,
ligosaccharides; LPS, lipopoly-
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ll rights reserved.responsible for 80% of the meningococcal diseases in Europe and 50%
in the United States, a preventive vaccine against serogroup B is still
missing [1–27]. The use of a glycoconjugate approach for serogroup B
vaccination is hampered by the close structural similarity between the
bacterial capsular polysaccharides and the sialic acid surface of
developing human brain [3]. As a consequence, vaccine development
for serogroup B has focused on the use of immunogenic outer
membrane proteins. Initial attempts to achieve immunization against
this serogroup using the integral membrane protein porin A (PorA)
achieved only partial success. This was due to the high degree of
sequence diversity of the PorA family across different meningococcal
strains, which would require a difﬁcult multivalent approach [28].
One relevant factor affecting the immunogenic properties of outer
membrane proteins is their degree of exposure to the extracellular
space. In the case of PorA for example, anti-porin bactericidal
antibodies recognize only a few surface exposed loops that emerge
from the surface of the outer membrane [4]. Among the factors
affecting the exposure of meningococcal antigens is the presence of a
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In the case of porin B (PorB), it was shown that membrane-bound
lipopolysaccharides with different chain lengths were able to shield
PorB epitopes from the antibodies, reducing the efﬁcacy of this class of
proteins as vaccine candidate [5].
Recently, a new family of meningococcal outer membrane
lipoproteins, LP2086 (also known as factor H binding protein, fHBP,
or GNA1870), was found to induce bactericidal antibodies, and is
presently being tested in humans as potential vaccine candidate
against serogroup B meningococci [6]. Based on their genetic
sequence, members of the LP2086 family were divided into two
subfamilies, subfamily A and B [5,7]. The structure of the variant
LP2086-B01 (PDB entry: 2KDY; Genbank accession number:
AY330406) in micellar solution revealed a fold consisting of three
regions. Two structured domains (the N-domain spanning residues
21–140, and the C-domain spanning residues 141–261), and a 20
residue N-terminal ﬂexible chain (spanning residues 1–20), which
anchors the protein to the membrane through a lipid moiety at
residue 1 (tripalmitoyl-S-glycerol-cysteine) [8,9]. The N-terminal
chain was suggested to act as a ﬂexible spacer that separates the
protein from the membrane surface and accommodates the layer of
lipo-oligosaccharides (LOS) that surround the outer membrane of the
bacteria. A topological model of the protein in the membrane was
suggested based on binding experiments with monoclonal antibodies
(mAb), and ﬂow cytometry experiments on whole meningococcal
cells [8]. LP2086-B01 was proposed to anchor the outer surface of the
bacteria with one face of the protein oriented toward the extracellular
space, while the opposite region connecting the N-terminal chain to
the main fold faces toward the membrane surface [8].
In addition to steric effects that may come into play with the
membrane and the LOS, the dynamic properties of membrane bound
antigen may also play an important role in antibody–antigen
recognition. In particular, lipidated membrane proteins embedded
or seating on the surface of the lipo-oligosaccharides can experience
restricted tumbling motion which makes certain regions of the
protein inaccessible to the immune system.
As a ﬁrst step towards characterizing the dynamic properties of
LP2086-B01 in a system that mimics the biological membrane, we
studied the backbone dynamics of the lipidated variant LP2086-B01 in
micellar solution. Detergent micelles have been extensively used as
membranemimicking systems for the study of membrane proteins by
solution NMR spectroscopy [10,11]. Similarly to biological mem-
branes, these systems provide a hydrophobic core that accommodates
hydrophobic regions of the protein, combined to a surface of charged
head-groups that mimics the phosphate layer of the membrane.
In the present work, we have compared the dynamic properties of
the lipidated LP2086-B01 with the non-lipidated free protein in
solution. Our data shows that for the protein–micelle complex the R2
relaxation rates increase with respect to the protein in the detergent-
free sample. However, the magnitude of the increase in R2 is not
consistent with the substantially higher molecular weight of the
protein–micelle complex. Based on the aggregation number, and the
molecular weight of the detergent, a doubling in themolecular weight
of the protein–micelle complex with respect to the micelle-free
protein is estimated. Our NMR data on the other hand shows only
minor changes in peak widths for LP2086-B01 in micellar solution.
Since the protein is bound to the micelle through a 20 residue ﬂexible
N-terminal chain, and NOEs with the detergent are observed only for
the ﬁrst two residues of the unstructured N-terminus, we concluded
that the main fold of the protein is not in contact with the micelle. We
propose that the changes observed in the dynamic properties of the
micelle-bound protein arise from motional restrictions imposed by
the micelle-bound N-terminal chain which hamper the protein from
tumbling istropically. The implications of these motional restrictions
in antibody binding and the possible role of the lipo-oligosaccharides
layer are discussed.2. Materials and methods
2.1. Protein expression and puriﬁcation
Expression and puriﬁcation of lipidated rLP2086-B01 was per-
formed as reported [6]. 15N labeled rP2086-B01 was expressed from a
pET9a vector, transformed in E. coli BLR(DE3)pLysS [6]. For the
perdeuterated protein, cells were grown in minimum media contain-
ing 50 μg kanamycin in 99% D2O, and enriched with 2 g/L 15N-
ammonium sulfate (Cambridge Isotope Laboratories). Expression was
performed at 37 °C for 14 h after induction with 1 mM isopropyl β-D-
thiogalactopyranoside (IPTG).
2.2. Production of Fab fragment from monoclonal antibodies
Fab fragments were obtained through papain digestion of
monoclonal MN86-1042-2. Full length MN86-1042-2 antibody was
dialyzed for 4 h in 20 mM phosphate buffer, 10 mM EDTA at pH 7.0.
The dialyzed mAb was then concentrated to 0.5 ml and combined
with 0.5 ml of digestion buffer (20 mM cysteine HCl in 20 mM
phosphate buffer, 10 mM EDTA, pH 7.0). The solution was then
incubated overnight at 37 °C with immobilized papain (Thermo) in a
glass tube under gentle agitation. The digested Fab fragment was
added to 1.5 ml of 10 mM TRIS buffer, pH 7.5, and the immobilized
papain was removed by centrifugation. The digestion mixture was
dialyzed for 3 h in the binding buffer (20 mM phosphate buffer, 0.1 M
citric acid, pH 7.0) and the Fab fragment was then isolated using a
protein A (GE Healthcare) column eluting at 1 ml/min.
2.3. NMR sample preparation and NMR spectroscopy
NMR samples were prepared by dialysis of the lipidated
rLP2086-B01 in 30 mM phosphate buffer, 90 mM NaCl containing
1% Zwittergent 3-12 (30 mM) at pH 7.4. The ﬁnal protein
concentration was 0.8 mM. T1, T2 and 15N(1H) NOE relaxation
experiments were recorded at a temperature of a 303.15 K, on a
Bruker Avance spectrometer operating at Larmor frequencies of 700
MHz and 600 MHz, equipped with triple resonance cryoprobes. All
experiments were recorded using standard Bruker pulse sequences.
Duplicate T1, T2 and 15N(1H) NOE experiments were recorded with
spectral widths of 12,626 Hz and 2199 Hz in the direct (1H) and
indirect (15N) dimensions respectively. For the T1 and T2 experi-
ments, 28 scans were accumulated over 2048 complex points in the
1H, and 256 complex points in the 15N dimension. Decoupling of 1H
from 15N during acquisition was obtained through a GARP pulse
sequence. Relaxation delays between acquisitions were 3 s for the
T1 experiments, 6 s for T2, and 3 s for the 15N(1H) NOE
experiments. Different T1 experiments were recorded with inver-
sion recovery times of 10, 20, 40, 180, 300, 500, 800, 1300 and
2000 ms. T2 experiments were acquired with delay times of 10, 20,
40, 60, 100, 150, 200 and 350 ms. 15N(1H)NOE was measured as
difference between two datasets, one recorded with a presaturation
period of 3 s using a train of 120 degree proton hard pulses
separated by 5 ms intervals, and one with no initial saturation.
Saturated and unsaturated spectra were recorded in an interleaved
manner.
2.4. Other NMR samples
The spectra of tripalmitoyl-S-glycerol-cysteine (Novabiochem)
were recorded in CDCl3. The spectra of Zwittergent 3-12 were
recorded in phosphate buffer. Assignment of the 1H resonances for
these two compounds was accomplished through 2D 1H,1H COSY, 2D
13C HMBC and 2D 13C HSQC experiments. NOEs between the lipidated
protein, the detergent and the lipid moiety were assigned using a 3D
15N edited NOESY with an 15N-labeled rLP2086-01.
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Data were processed using the NMRPipe suite [12]. R1 and R2
relaxation rates and standard deviations were determined by ﬁtting
peak intensities with a single exponential decay curve using the built-
in function in Sparky [13]. Duplicate experiments were recorded for
each mixing time. Error on the peak intensities was calculated as
standard deviation of duplicate data points.
Heteronuclear 15N(1H) NOE relaxations were calculated from the
ratio of the peak intensities of the saturated to the unsaturated
spectra. Standard deviations on the NOE were calculated according to
the following formula [14]:
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2.6. Antibody binding by NMR
Binding of Fab fragment to the rP2086-B01 antigen was performed
by adding unlabeled MN86-1042-2 Fab to the non-lipidated protein
uniformly labeled with 15N and 2H. Two experiments were recorded
with protein to Fab fragment ratios of 1:0.5 and 1:1, at 30 °C, and a
protein concentration of 200 μM. Identiﬁcation of the residues involved
in antibody interaction was accomplished by identifying peaks
experiencing above average intensity reduction or chemical shift
perturbation, through two-dimensional 1H,15N HSQC experiments.
2.7. Flow cytometry
Monoclonal antibodies used in ﬂow cytometry experiments were
obtained from mice immunized with rLP2086 variant B01. BacterialFig. 1. Graphical representation of LP2086-B01 anchored to a detergent micelle. Left: the 20 r
3-12 through the tripalmitoyl-S-glycerol-cysteine moiety. Based on the length of a fully exte
to achieve a maximum length of 55 Å above the micelle. The protein and the detergents w
between residue Cys-1, Zwittergent 3-12, and the tripalmitoyl-S-glycerol-cysteine from a 3D
Zwittergent 3-12. Bottom: assigned 1D 1H spectrum of tripalmitoyl-S-glycerol-cysteine.cells were grown to an OD650 of 0.45–0.55 and then ﬁxed in 1%
paraformaldehyde for 10 min. The bacteria were then plated and
washed in 1% BSA/PBS. Following the addition of MN86-1042-2
antibody or 1042-2 Fab fragment, cells were resuspended and added
to an ice bath for 30 min. Mouse IgG and MN86-994-11 were used as
negative and positive controls, respectively. After two washes in 1%
BSA/PBS, biotinylated goat anti-mouse IgG (subclasses 1+2a+2b+3)
(Jackson Immunoresearch) or biotinylated anti-mouse IgG (Fab
speciﬁc) (Sigma) was added to the cells and incubated on ice for
30 min. Cells were washed twice, resuspended in streptavidin–PE (BD
Biosciences) and added to an ice bath for an additional 30 min. After
two washes in 1% BSA/PBS, the cells were resuspended in 1%
paraformaldehyde. Fluorescence intensity was recorded on a Becton
Dickinson LSR II ﬂow cytometer and data analyzed with FlowJo
version 7 software (Treestar). The mean ﬂuorescence intensity (MFI)
of the PE channel was determined for each sample after gating on
bacterial cells.
3. Results
3.1. Backbone dynamics
The NMR structure of rLP2086-B01 in micellar solution revealed a
novel fold consisting of two domains in contact through two
hydrophobic patches [8,9]. The main globular part of the protein is
linked to the micelle through a ﬂexible chain (residues 1–20) that
anchors the micelle through a tripalmitoyl-S-glycerol-cysteine lipid
moiety at cysteine 1 (Fig. 1). The folded part of the protein was shown
to have no contacts with the micelle. In fact, NOEs between rLP2086-
B01 and the micelle are observed only for residues Cys-1 and Gly-2 at
the N-terminal chain [8]. NOE assignment between rLP2086-B01, the
detergent (Zwittergent 3-12), and the lipid moiety is shown in Fig. 1.esidue unstructured chain anchors LP2086-B01 to the surface of a micelle of Zwittergent
nded 20 residue polypeptide chain, the unstructured N-terminal is estimated to be able
ere drawn in scale using the program PyMOL [25]. Center: tentative NOE assignments
15N-NOESY of rLP2086-B01 in micellar solution. Right top: assigned 1D 1H spectrum of
Fig. 2. Longitudinal and transverse relaxation rates of LP2086-B01 measured at 700 MHz. Comparison of (A) longitudinal (R1) and (B) transverse (R2) relaxation rates for the non-
lipidated protein rP2086-B01 in the absence of detergent (ﬁlled circles), and for the lipidated rLP2086-B01 in micellar solution (open circles).
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LP2086-B01 in both lipidated micellar solution and non-lipidated
protein in absence of detergent, measured at 700 MHz. An increase in
the transverse relaxation rates R2 is observed, from an average value
of 20.4±1.3 s−1 for the structured part of the non-lipidated protein toFig. 3. Backbone dynamics of rLP2086-B01 inmicellar and non-micellar samples. (A) R2/R1 an
rLP2086-B01 in 1% Zwittergent 3-12 (open circles) and for the non-lipidated rP2086-B01 in34.1±6.1 s−1 for the lipidated protein in detergent micelle (Fig. 2B).
The longitudinal relaxation rates R1 on the other hand, being less
sensitive to increases in correlation times, have comparable values in
both conditions (Fig. 2A). The R2/R1 ratios and R2⁎R1 for lipidated
LP2086-B01 in micellar solution and for non-lipidated protein in thed (B) R2⁎ R1 values and (C) heteronuclear 15N(1H) NOE for themicelle-bound lipidated
the absence of detergent (closed circles).
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With the exception of the N-terminal chain and some loops, the values
of R2/R1 and R2⁎R1 are uniform across the structured parts of the
protein indicating that in both cases, the protein tumbles in solution
as a unique globular unit with the two domains moving as one. For the
non-lipidated rP2086-B01, the average R2/R1 value is 23.8±2.6 for
the structured parts of the protein, which is consistent with the
molecular weight of the monomeric protein of 27.5 kDa. As evident
from Fig. 3A and B, small differences in the average R2/R1 and R2⁎R1
are observable between the non-lipidated protein and the lipidated
protein in micellar solution. We observe an increase in the R2/R1
average value for the lipidated rLP2086-B01 in 1% Zwittergent 3-12, to
38.7±8.0.
The N-terminal chain of the lipidated LP-2086-B01 may extend by
more than 50 Å above the surface of the micelle, based on the
estimated length of a fully extended 20 residue chain. In addition, only
NOEs between the ﬁrst two residues and the micelle were observed,
leading us to conclude that the main body of the protein is not in
contact with the micelle. This could explain the small differences
observed in the R2/R1 and R2⁎R1 values and the corresponding peak
widths between the two forms of the protein. Since the aggregation
number of Zwittergent 3-12 is 55 (18.5 kDa micelle), the estimated
molecular weight of the complex is approximately 46 kDa. Despite the
doubling in molecular weight, the peak widths on the 2D 1H,15N-
HSQC spectra remained remarkably sharp showing only small
increases in line width. The half-height line width for 1H and 15N for
the structured parts of the protein increased from average values of
31.2±3.5 Hz (1H) and 11.4±1.1 Hz (15N) for the non-lipidated
protein, to 38.7±4.6 Hz (1H) and 12.8±2.0 Hz (15N) for the micelle-
bound lipidated protein. These line widths are sharper than what is
usually observed for integral membrane proteins of comparable
molecular weight in micellar solutions. In fact, the study of membrane
proteins by NMR spectroscopy in micellar solutions routinely requires
higher temperatures (up to 60 °C) in order to decrease the line widths
by increasing the protein tumbling rate in solution [15].
The 15N(1H) NOE valuesmeasured at 700MHz for the lipidated and
non-lipidated proteins are displayed in Fig. 3C, showing very similar
values (within experimental errors) for the two forms of the protein.
The average NOE values for the structured parts of the protein are
0.89±0.11 and 0.87±0.08 for the N-domain and the C-domain,
respectively. The only exceptions are some of the loops (regions 47–
50, 89–96, 121–133, 150–154, and 250–252) which display higher
backbone mobility as indicated by their negative or below 0.7 NOE
values. Interestingly, the short amphipathicα-helix spanning residues
19–26 has several residues with NOE values below 0.7 indicating that
this helix is dynamic in nature. The high ﬂexibility of the N-terminal
chain is evidenced by the negative values of 15N(1H) NOE as shown in
Fig. 3C, with residues Cys-1 and Gly-2 being the exception in the
lipidatedproteinwithpositiveNOEvalues (0.31±0.01 and0.07±0.07),
in agreement with being buried into the surface of the micelle.
We suggest that the observed increase in R2 for the lipidated
protein arises from steric restrictions imposed by the ﬂexible N-
terminal chain anchored to the micelle. Although the free protein in
solution can tumble isotropically, the restrain from the N-terminal
linker may limit its ability to tumble freely in solution. Interestingly,
hydrodynamic calculations conducted with the program Hydronmr
[16] produce average values of R2/R1 for the free protein of 36.0±3.2
and 26.7±2.4 at 700 and 600 MHz, respectively, which compare well
with the experimental values of 38.7±8.0 and 25.8±7.6 observed for
rLP2086-B01 in micellar solution. However, the analysis of rLP2086-
B01 relaxation data through standard dynamics methodologies based
on the model-free approach [17] failed to converge probably due to
these unconventional dynamic properties of the protein in complex
with the micelle. In contrast to the changes observed in the transverse
relaxation rates, the 15N(1H) NOE and the R1 values are virtually
identical for the micelle-bound and the free protein in solution,indicating that the presence of the micelle affects the overall tumbling
of the whole protein but not the backbone ﬂexibility.
3.2. Epitope mapping with Fab fragment MN86-1042-2
Our interest in conﬁrming the earlier proposed antigen topology in
the bacterial membrane [8] led us to perform additional studies of LP-
2086-B01 with MN86-1042-2, a subfamily B speciﬁc monoclonal
antibody. Spectral perturbations such as line broadening or chemical
shifts changes are usually observed in the target protein upon
interaction with a ligand. For instance, in the case of antigen-Fab
interacting with afﬁnities in the μM range, the residues involved in
binding can generally be identiﬁed by observing differential line
broadening upon titration of unlabeled Fab fragment to the 15N
labeled antigen [8,18,19]. For antibodies that bind tighter (in the nM-
pM range), chemical shift perturbation of uniformly 2H/15N labeled
antigen and unlabeled Fab fragment can be observed [14,15].
Therefore, residues that are in direct contact with a Fab fragment
can be identiﬁed by changes observable in a 1H-15N correlation
experiment.
Among the pool of monoclonal antibodies identiﬁed in our
laboratory, we selected MN86-1042-2 due to its speciﬁcity to
subfamily B of LP2086 and also for its high afﬁnity for the protein.
The afﬁnity of MN86-1042-2 to rP2086-B01, asmeasured from surface
plasmon resonance experiments, is ∼20 nM (data not shown). Fig. 4A
shows the changes observed in the 1H-15N HSQC of perdeuterated 15N
labeled rLP2086-B01 in the presence of Fab-1042-2, at ratios of 1:0.5
and 1:1 antigen-Fab. As anticipated, binding with the Fab fragment
causes a large reduction in the intensities of the HSQC peaks.
However, for several peaks which belong to residues located in the
N-domain, an above average reduction in intensity is observed
(shown on the surface diagram of LP-2086-B01 in red, Fig. 4B). In
addition, peak shifts for other residues also located at the N-domain
are observed, which is expected due to the slow exchange between
the free and bound forms (shown on the surface diagram of LP-2086-
B01 in blue, Fig. 4B). The residues on the N-domain that are affected
by the binding of MN86-1042-2 belong to a region of the protein that
was previously proposed to be oriented toward the extracellular space
[8]. Fig. 4C shows that both MN86-1042-2 monoclonal antibody and
MN86-1042-2 Fab fragment can bind equally well to LP2086-B01 on
the surface of intact meningococcal B cells, showing that the binding
epitope of this antibody is not affected by the presence of the LOS on
the outer bacterial surface [8]. Although our data is not sufﬁcient to
narrow the speciﬁc residues that form the binding epitope of MN86-
1042-2, our results clearly indicate that the N-domain is mostly
involved in the recognition of MN86-1042-2. In agreement with the
NMR binding, competitive ﬂow cytometry experiments using over-
lapping linear dodecapeptides spanning the entire primary sequence
of LP2086-B01 (data not shown) did not identify any peptide that
competes for this antibody. This supports the hypothesis that the
MN86-1042-2 monoclonal antibody interacts with a conformational
epitope spanning a broad region of the protein. In sum, our NMR
experiments indicate that the binding of MN86-1042-2 Fab fragment
encompasses a large conformational epitope that is extended over a
broad region of the N-domain exposed to the extracellular space.
4. Discussion
The ability of surface proteins to elicit bactericidal antibodies
depends not only on the intrinsic immunogenic properties encoded in
the protein sequence, but also on the accessibility of these binding
epitopes to the host immune system. This accessibility can be affected
by the presence of other molecular components of the outer bacterial
membrane such as the capsule and the layer of lipo-oligosaccharides.
The latter were shown to affect the antigenicity of PorB proteins
diminishing their efﬁcacy as anti-meningococcal vaccines [5]. The
Fig. 5. Dynamic model of LP2086-B01 in the outer bacterial membrane. (A) The surface
of interaction with factor H and the binding epitopes for monoclonal antibodies MN86-
440-18, MN86-1075-6 andMN86-1042-2 are overlapped and located on one face of the
antigen exposed to the extracellular space. (B) The presence of a layer of lipo-
oligosaccharides may impose limitations to the dynamics of LP2086-B01, making some
epitopes inaccessible by the antibodies. This model is in agreement with the
identiﬁcation of antibodies that recognize the free protein but not the membrane
bound LP2086-B01 in whole meningococcal cells [8].
Fig. 4. Binding of a Fab fragment derived from the monoclonal MN86-1042-2 with
rP2086-B01. (A) 2D HSQC spectra of representative residues that experience changes
upon addition of MN86-1042-2. Free rP2086-B01 (red); rP2086-B01/MN86-1042-2
complex in ratio 1:0.5 (blue); and rP2086-B01/MN86-1042-2 complex in ratio 1:1
(green). (B)Most of the residues affected by the binding with MN86-1042-2 are located
on the N-domain. Blue: residues which display peak shifts by more than one line width
from the peak of the free protein. Red: residues which peaks that experience above
average reduction in signal intensity. Dark gray: unassigned residues due to either
exchange with the solvent at pH 7.4 or due to deuteration following the expression of
the protein in 99% D2O. (C) Flow cytometry of Fab fragment derived from the
monoclonal MN86-1042-2 (green) and the full-length mAb MN86-1042-2 (red) to
MnB show comparable activities.
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resides in their ability to extend above the layer of lipo-oligosacchar-
ides as shown in the model proposed in Fig. 5A. Very importantly, a
recent report indicated that the presence of the capsular polysacchar-
ides does not affect the binding of antibodies directed to LP2086 [22].
The layer of lipo-oligosaccharides, however, may impose addi-
tional motional restrictions that limit the protein range of motion
above the membrane, while partially shielding one face of the antigen
from the antibodies (Fig. 5B). This model would explain the existence
of two monoclonal antibodies identiﬁed in our laboratories (MN86-
813 andMN86-626-15) that recognize the free protein in solution, but
do not interact with the membrane bound LP2086 in intact
meningococcal cells [8]. For these two mAbs, linear epitopes were
identiﬁed on one face of the N-domain. On the opposite face of the N-
domain, on the other hand, the subfamily B speciﬁc monoclonal
MN86-1042-2 presented in this work, and two other mAbs (the
subfamily B speciﬁc MN86-440-18 and the broad spectrum MN86-
1075-6) previously studied in our laboratories [8], present over-lapping epitopes as shown in Fig. 5A. Since the binding epitopes of
these mAbs overlap on the same face of the N-domain, our work
further strengthens the importance of the N-domain in antibody
recognition, and supports our hypothesis that LP2086-B01 orients one
face of the protein toward the host complement system (Fig. 5A).
This model is also in agreement with the recently reported crystal
structure of one variant of the LP2086 family in complex with the 6th
and 7th domains of human factor H [23]. The structure of the complex
reveals that factor H binds rP2086 on the face of the protein exposed to
the extracellular space, and its binding surface partially overlaps with
the binding epitopes of MN86-1042-2, MN86-440-18 and MN86-
1075-6 (Fig. 5A). As revealed by sequence alignment of 172 unique
LP2086 sequences, this face of the protein is populated by residues that
are responsible for deﬁning the speciﬁcity to the two subfamily A and B
of serogroup B meningococci [24]. In combination with the observa-
tion that monoclonal antibodies against LP2086 mainly display
subfamily speciﬁc afﬁnities, the presence of an exposed surface of
subfamily speciﬁc residues can partially explain the immunogenic
character of LP2086 [8].
In conclusion, our dynamics data together with binding experi-
ments with the subfamily B speciﬁc monoclonal MN86-1042-2
support our previously suggested topological model LP2086-B01 on
the outer surface of N. meningitides. The degree of exposure of the
antigen to the extracellular space is very likely affected by the dynamic
properties of the protein when bound to the membrane surface.
Membrane bound antigens that are partially immersed in the layer of
oligosaccharides could experience a restricted range of motions, thus
preventing access of certain epitope regions to the antibody (Fig. 5B).
Our dynamics experiments in micellar solution in the absence of the
lipo-oligosaccharide layer suggest that even though the lipidated
protein is not in direct contact with themicelle, themembrane-bound
linker itself seems to induce structural restrictions that affect the
protein dynamics which deviate from a fully isotropic tumbling.
However, since antibody MN86-1042-2 is still able to bind to the
protein, this antigenic face of the LP-2086-B01 is still available, despite
the restrictions on protein dynamics imposed by the membrane and
the LOS layer. A complete dynamic picture of LP2086-B01 in a realistic
membranemimicking systemwould require the incorporation of lipo-
oligosaccharides in micellar solutions of rLP2086-B01, which would
93A. Mascioni et al. / Biochimica et Biophysica Acta 1798 (2010) 87–93provide a more complete assessment of the degree of restriction that
the LOS layer imposes on the protein tumbling and epitope exposure.
In fact, it is interesting to consider an extreme scenario where non-
covalent interactions between the protein and the LOS could induce a
structural change on the N-terminal, thus bringing the antigen in
closer proximity to the membrane. Experiments are ongoing in our
laboratory to test the effect of the LOS layer on the protein structure
and dynamics.
Acknowledgements
We are thankful to Lidia Mosyak and Will Somers for useful
discussion on the manuscript. We also thank Amy Tam, May Tam,
Wayne Stochaj, Laura Lin, Ron Kriz andMark Stahl for their support on
the experimental work.
References
[1] N. Rosenstein, B. Perkins, D. Stephens, T. Popovic, J. Hughes, Meningococcal
disease, N. Engl. J. Med. 344 (2001) 1378–1388.
[2] EU-INS, Invasive Neisseria meningitidis in Europe. London: Health Protection
Agency; 2006. www.euibis.org.
[3] Centers for Disease Control and Prevention, Active bacterial core surveillance.
Atlanta: Centers for Disease Control and Prevention. http://www.cdc.gov/
ncidod/dbmd/abcs/meth-surv-pop.htm.
[4] J.T. Poolman, Development of a meningococcal vaccine, Infect agents Dis. 4 (1995)
13–28.
[5] C.L Vermont, H.H. van Dijken, A.J. Kuipers, C.J.P. van Limpt, W.C.M. Keijzers, A. van
der Ende, R.d. Groot, L. van Alphen, G.P.J.M. van den Dobbelsteen, Cross-reactivity
of antibodies against PorA after vaccination with a Meningococcal B outer
membrane vesicle vaccine, Infect. Immun. 71 (2003) 1650–1655.
[6] J. van den Elsen, J.N. Herron, P. Hoogerhout, J. Poolman, E. Boel, T. Logtenberg, J.
Wilting, D. Crommelin, J. Kroon, P. Gros, Bactericidal antibody recognition of a
PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in
complex with a ﬂuorescein-conjugated peptide, Proteins 29 (1997) 113–125.
[7] A.T. Bentley, P.E. Klebba, Effect of lipopolysaccharide structure on reactivity of
antiporin monoclonal antibodies with the bacterial cell surface, J. Bacteriol 170
(1988) 1063–1068.
[8] L.D. Fletcher, L. Bernﬁeld, V. Barniak, J.E. Farley, A. Howell, M. Knauf, P. Ooi, R.P.
Smith, P. Weise, M. Wetherell, X. Xie, R. Zagursky, Y. Zhang, G.W. Zlotnick, Vaccine
potential of the Neisseria meningitidis 2086 lipoprotein, Infect. Immun. 72 (2004)
2088–2100.
[9] S. Pillai, A. Howell, K. Alexander, E.B. Bentley, H.Q. Jiang, K. Ambrose, D. Zhu, G.
Zlotnick, Outer membrane protein (OMP) based vaccine for Neisseria meningitidis
serogroup B, Vaccine 23 (2005) 2206–2209.
[10] A. Mascioni, B. Bentley, R. Camarda, D. Dilts, P. Fink, V. Gusarova, S. Hoiseth, J.
Jacob, S. Lin, K. Malakian, L. McNeil, T. Mininni, F. Moy, E. Murphy, E. Novikova, S.
Sigethy, Y. Wen, G. Zlotnick, D.H.H. Tsao, Structural basis for the immunogenic
properties of the meningococcal vaccine candidate LP2086, J. Biol. Chem. 284
(2009) 8738–8746.[11] F. Cantini, D. Veggi, S. Dragonetti, S. Savino, M. Scarselli, G. Romagnoli, M. Pizza, L.
Banci, R. Rappuoli, Solution structure of the factor H-binding protein, a survival
factor and protective antigen of Neisseria meningitidis, J. Biol. Chem. 284 (2009)
9022–9026.
[12] F. Porcelli, B.A. Buck-Koehntop, S. Thennarasu, A. Ramamoorthy, G. Veglia,
Structures of the dimeric and monomeric variants of magainin antimicrobial
peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR
spectroscopy, Biochemistry 45 (2006) 5793–5799.
[13] F. Porcelli, R. Verardi, L. Shi, K.A. Henzler-Wildman, A. Ramamoorthy, G. Veglia,
NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in
dodecylphosphocholine micelles, Biochemistry 47 (2008) 557–5565.
[14] F. Delaglio, S. Grzesiek, G.W. Vuister, G. Zhu, J. Pfeifer, A. Bax, , NMRPipe: a
multidimensional spectral processing system based on UNIX pipes, J. Biomol.
NMR 6 (1995) 277–293.
[15] T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco.
[16] N.A. Farrow, R. Muhandiram, A.U. Singer, S.M. Pascal, C.M. Kay, G. Gish, S.E.
Shoelson, T. Pawson, J.D. Forman-Kay, L.E. Kay, Backbone dynamics of a free and
phosphopeptide-complexed Src homology 2 domain studied by 15N NMR
relaxation, Biochemistry 33 (1994) 5984–6003.
[17] B.A. Buck-Koehntop, A. Mascioni, J.J. Buffy, G.J. Veglia, Structure, dynamics, and
membrane topology of stannin: a mediator of neuronal cell apoptosis induced by
trimethyltin chloride, J. Mol Biol. 354 (1995) 652–665.
[18] J. García de la Torre, M.L. Huertas, B. Carrasco, HYDRONMR: prediction of NMR
relaxation of globular proteins from atomic-level structures and hydrodynamic
calculations, J. Magn. Reson. B 147 (2000) 138–146.
[19] G. Lipari, A. Szabo, Model-free approach to the interpretation of nuclear magnetic
resonance relaxation in macromolecules. 1. Theory and range of validity, J. Am.
Chem. Soc. 104 (1982) 4546–4559.
[20] H. Matsuo, K. Walters, K. Teruya, T. Tanaka, G. Gassner, S. Lippard, Y. Kyogoku, G.
Wagner, Identiﬁcation by NMR spectroscopy of residues at contact surfaces in
large, slowly exchanging macromolecular complexes, J. Am. Chem. Soc. 121
(1999) 9903–9904.
[21] K. Walters, G. Gassner, S. Lippard, G. Wagner, Structure of the soluble methane
monooxygenase regulatory protein B, Proc. Natl. Acad. Sci. 96 (1999) 7877–7882.
[22] X. Huang, X. Yang, B. Luft, S. Koide, Structure-based design of a second-generation
Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA,
J. Mol. Bio. 281 (2005) 61–67.
[23] W. Ding, X. Huang, X. Yang, J. Dunn, B. Luft, S. Koide, C. Lawson, Structural
identiﬁcation of a key protective B-cell epitope in Lyme disease antigen OspA, J.
Mol. Bio. 302 (2000) 1153–1164.
[24] L. McNeil, E. Murphy, X. Zhao, S. Guttmann, S. Harris, A. Scott, C. Tan, M. Mack, I.
Dasilva, K. Alexander, K. Mason, H. Jiang, D. Zhu, T. Mininni, G. Zlotnick, S. Hoiseth,
T. Jones, M. Pride, K. Jansen, A. Anderson, Detection of LP2086 on the cell surface of
Neisseria meningitidis and its accessibility in the presence of serogroup B capsular
polysaccharide, Vaccine 27 (2009) 3417–3421.
[25] M. Schneider, B. Prosser, J. Caesar, E. Kugelberg, S. Li, Q. Zhang, S. Quoraishi, J. Lovett,
J. Deane, R. Sim, P. Roversi, S. Johnson, C. Tang, S. Lea,Neisseria meningitidis recruits
factor H using proteinmimicry of host carbohydrates, Nature 458 (2009) 890–893.
[26] E. Murphy, L. Andrew, K. Lee, D. Dilts, K. Ambrose, R. Borrow, J. Findlow, M. Taha,
M.A. Deghmane, P. Kriz, M. Musilek, J. Kalmusova, D. Caugant, T. Alvestad, L.
Mayer, X. Wang, D. Martin, A. von Gottberg, K. Klugman, A. Anderson, K. Jansen, G.
Zlotnick, S. Hoiseth, Sequence diversity of the factor H binding protein vaccine
candidate in epidemiologically relevant strains of serogroup B Neisseria
meningitidis, JID 200 (2009) 379–389.
[27] W. L. DeLano, The PyMOLMolecular Graphics System. 2002. http://www.pymol.org.
